Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
Labeling: Incorrect or Missing Lot and/or Exp Date
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Subpotent drug
Subpotent drug
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at…
Subpotent drug
Subpotent drug
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles…
Subpotent drug
Subpotent drug
CGMP Deviations
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Non-Sterility: Due to presence of Aspergillus penicillioides.
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Non-Sterility: Due to presence of Aspergillus penicillioides.